Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VapeAway is a consumer healthcare company that specializes in nicotine cessation technology. The company's flagship product is a patented tapering system designed to help individuals quit vaping by gradually reducing nicotine intake through a series of precision-engineered filters. Unlike pharmacological interventions, VapeAway provides a mechanical solution that allows users to continue their behavioral habits while weaning off the chemical dependency. The system is aimed at both individual consumers and healthcare providers looking for non-drug alternatives to smoking and vaping cessation. By offering a structured, step-down approach, the company seeks to address the physical and psychological aspects of vaping addiction.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VapeAway.